105 related articles for article (PubMed ID: 1619068)
1. Serum aminoterminal propeptide of type III procollagen in the management of methotrexate-induced fibrogenesis.
Kürkçüoğlu N; Oz G
J Am Acad Dermatol; 1992 Jul; 27(1):139. PubMed ID: 1619068
[No Abstract] [Full Text] [Related]
2. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
3. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
[TBL] [Abstract][Full Text] [Related]
4. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
Zachariae H; Søgaard H; Heickendorff L
Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
[TBL] [Abstract][Full Text] [Related]
5. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis.
Kanzler MH; Gorsulowsky D
J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):509. PubMed ID: 1564165
[No Abstract] [Full Text] [Related]
6. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
[TBL] [Abstract][Full Text] [Related]
7. Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.
Mitchell D; Smith A; Rowan B; Warnes TW; Haboubi NY; Lucas SB; Chalmers RJ
Br J Dermatol; 1990 Jan; 122(1):1-7. PubMed ID: 2297495
[TBL] [Abstract][Full Text] [Related]
8. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate.
Biasi D; Bambara LM; Carletto A; Casaril M; Capra F; Caramaschi P; Corrocher R
J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
Oogarah PK; Rowland PL; Mitchell DM; Smith A; Chalmers RJ; Rowan B; Haboubi NY
Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.
Zachariae H; Søgaard H; Heickendorff L
Dermatology; 1996; 192(4):343-6. PubMed ID: 8864370
[TBL] [Abstract][Full Text] [Related]
11. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum aminoterminal procollagen type III peptide in methotrexate-induced hepatic fibrosis.
Fairris GM; Brooks B; Tanner A
Br J Dermatol; 1986 Apr; 114(4):520-1. PubMed ID: 3964554
[No Abstract] [Full Text] [Related]
13. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
[TBL] [Abstract][Full Text] [Related]
14. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
Zachariae H; Heickendorff L; Søgaard H
Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
[TBL] [Abstract][Full Text] [Related]
15. The blue glass and the predictive value of serum amino-terminal propeptide of type III procollagen as a marker of liver fibrosis.
Rojkind M
Hepatology; 1984; 4(5):977-8. PubMed ID: 6479861
[No Abstract] [Full Text] [Related]
16. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
Bentsen KD; Henriksen JH; Bendtsen F; Hørslev-Petersen K; Lorenzen I
Hepatology; 1990 Jun; 11(6):957-63. PubMed ID: 2365293
[TBL] [Abstract][Full Text] [Related]
17. [Procollagen Type III-N-terminal peptide as an indicator of hepatic fibrogenesis].
Sajewicz Z; Poniewierka E
Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):325-6. PubMed ID: 2235718
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions.
Gressner AM; Tittor W; Negwer A
Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases.
Gressner AM; Tittor W; Negwer A; Pick-Kober KH
Clin Chim Acta; 1986 Dec; 161(3):249-58. PubMed ID: 3802532
[TBL] [Abstract][Full Text] [Related]
20. [Amino-terminal procollagen type-III peptide and hepatic fibrogenesis].
Castilla Cortázar A
Med Clin (Barc); 1993 Mar; 100(11):436. PubMed ID: 8464262
[No Abstract] [Full Text] [Related]
[Next] [New Search]